Telegraph

7x24 real-time news feed, auto refreshBeijing Time：

All A·Important B·Normal #仿制药 ✕
B
[State Food and Drug Administration: Support the quality improvement and upgrading of generic drugs and promote the transformation of generic drugs to high value-added and high-tech content] On September 20, Yang Sheng, deputy director of the State Food and Drug Administration, stated at a press conference of the State Council Information Office that he would support the quality improvement and upgrading of generic drugs, encourage the adoption of internationally advanced technologies and processes, promote the transformation of generic drugs into high value-added and high-tech content, improve the overall quality of drug supply, and allow people to use more good medicines and feel safe about medicines.
#generic drugs09-20 11:11
B
[Shi4 Pharmaceutical Group: Letermovir Injection received drug production registration approval] On September 10th, Shi4 Pharmaceutical Group issued a voluntary announcement that the company has obtained the drug production registration approval document from the China National Medical Products Administration for Letermovir Injection (12ml:240mg). This product belongs to Category 4 chemical drugs and is deemed to have passed the consistency evaluation. Letermovir injection is mainly used for cytomegalovirus (CMV) seropositive adult recipients who have received allogeneic hematopoietic stem cell transplantation to prevent cytomegalovirus infection and cytomegalovirus disease. It needs to be used in combination with basic infusion and should be used in the perioperative period of hematopoietic stem cell transplantation. Relying on the existing advantages of basic infusion, the Group continues to improve the therapeutic injection product pipeline, and this approval further enriches the perioperative product portfolio.
#stem cells#Chemical#Gene#cell#Virus#generic drugs#chemicals#Hong Kong stock trends09-10 12:04